Clinical Trial Update: The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC [Phase 2]

View source ↗

Summary

Phase 2 trial assessing induction and adjuvant camrelizumab with chemoradiation for locally advanced head and neck squamous cell carcinoma has completed enrollm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED